share_log

佐力药业:国金证券股份有限公司关于浙江佐力药业股份有限公司2024年半年度持续督导跟踪报告

Zhejiang Jolly Pharmaceutical: Sinolink's continuous supervision and follow-up report on Zhejiang Jolly Pharmaceutical Co., Ltd. for the first half of 2024.

SZSI ·  Jul 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more